Flex Pharma (FLKS) Reports Q4 Loss of $0.46/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/28/2026
- First Financial to acquire Hickory Point Bank in $111.3M deal
- Affirm Holdings (AFRM) Tops Q4 EPS by $3.77, Beats on Revenue
- Nasdaq, S&P 500 lifted by Nvidia's forecast; investors eye speech by Fed's Warsh
- Ovintiv adds 41,000 acres in Permian and Montney deals
- Russia says it could strike UK military targets in response to Kyiv's use of British missiles
Flex Pharma Reports Year End 2017 Financial Results
March 7, 2018 7:00 AM EST-- FLX-787 Exploratory MS Spasticity Results at the end of March --
-- FLX-787 Phase 2 ALS & CMT Clinical Studies Ongoing --
-- Cash to Mid 2019 --
Conference Call Scheduled Today at 9:00 a.m. ET
